These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1481 related articles for article (PubMed ID: 8747596)

  • 41. p53 expression is rare in cutaneous melanomas.
    Saenz-Santamaría MC; McNutt NS; Bogdany JK; Shea CR
    Am J Dermatopathol; 1995 Aug; 17(4):344-9. PubMed ID: 8600797
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Loss of membranous expression of beta-catenin is associated with tumor progression in cutaneous melanoma and rarely caused by exon 3 mutations.
    Demunter A; Libbrecht L; Degreef H; De Wolf-Peeters C; van den Oord JJ
    Mod Pathol; 2002 Apr; 15(4):454-61. PubMed ID: 11950921
    [TBL] [Abstract][Full Text] [Related]  

  • 43. p53 gene and cell cycling in uveal melanoma.
    Kishore K; Ghazvini S; Char DH; Kroll S; Selle J
    Am J Ophthalmol; 1996 May; 121(5):561-7. PubMed ID: 8610800
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Results of p53 analysis in pediatric malignancies in Poland.
    Fiszer-Maliszewska Ł; Czernik J; Sawicz-Birkowska K; Kazanowska B; Wojciechowska B
    Med Pediatr Oncol; 2003 May; 40(5):316-21. PubMed ID: 12652620
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lack of allelic deletion and point mutation as mechanisms of p53 activation in human malignant melanoma.
    Castresana JS; Rubio MP; Vázquez JJ; Idoate M; Sober AJ; Seizinger BR; Barnhill RL
    Int J Cancer; 1993 Oct; 55(4):562-5. PubMed ID: 8104906
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunoreactivity of new antibodies anti-p53 and anti-MDM-2 in paraffin embedded tissue samples.
    Andrejco M; Kaláb M; Oulton A; Kolár Z; Lichnovský V; Kod'ousek R; Vojtĕsek B
    Acta Univ Palacki Olomuc Fac Med; 1996; 140():63-7. PubMed ID: 9431695
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mutations in the TP53 gene in human malignant melanomas derived from sun-exposed skin and unexposed mucosal membranes.
    Ragnarsson-Olding BK; Karsberg S; Platz A; Ringborg UK
    Melanoma Res; 2002 Oct; 12(5):453-63. PubMed ID: 12394187
    [TBL] [Abstract][Full Text] [Related]  

  • 48. p53 protein expression and TP53 mutations in malignant melanomas of sun-sheltered mucosal membranes versus chronically sun-exposed skin.
    Ragnarsson-Olding B; Platz A; Olding L; Ringborg U
    Melanoma Res; 2004 Oct; 14(5):395-401. PubMed ID: 15457096
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevalence and prognostic significance of murine double minute protein-2 overexpression and P53 gene mutations in childhood acute lymphoblastic leukemia.
    Hendy OM; Elghannam DM; El-Sharnouby JA; Goda EF; El-Ashry R; Al-Tonbary Y
    Egypt J Immunol; 2008; 15(1):93-100. PubMed ID: 20306673
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Human bladder carcinoma cell lines as indicators of oncogenic change relevant to urothelial neoplastic progression.
    Rieger KM; Little AF; Swart JM; Kastrinakis WV; Fitzgerald JM; Hess DT; Libertino JA; Summerhayes IC
    Br J Cancer; 1995 Sep; 72(3):683-90. PubMed ID: 7669581
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lack of p53 mutations and loss of heterozygosity in non-cultured human melanocytic lesions.
    Papp T; Jafari M; Schiffmann D
    J Cancer Res Clin Oncol; 1996; 122(9):541-8. PubMed ID: 8781568
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Amplification of the mdm-2 gene and p53 abnormalities in uterine sarcomas.
    Seki A; Kodama J; Miyagi Y; Kamimura S; Yoshinouchi M; Kudo T
    Int J Cancer; 1997 Sep; 73(1):33-7. PubMed ID: 9334806
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ultraviolet B-induced melanoma in Monodelphis domestica occurs in the absence of alterations in the structure or expression of the p53 gene.
    Wang Z; Atencio J; Robinson ES; McCarrey JR
    Melanoma Res; 2001 Jun; 11(3):239-45. PubMed ID: 11468512
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular analysis for p53 and mdm2 in intracranial germ cell tumors.
    Iwato M; Tachibana O; Tohma Y; Nitta H; Hayashi Y; Yamashita J
    Acta Neuropathol; 2000 Jan; 99(1):21-5. PubMed ID: 10651023
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Expression of p53 protein in melanoma progression.
    Kanoko M; Ueda M; Nagano T; Ichihashi M
    J Dermatol Sci; 1996 Jun; 12(2):97-103. PubMed ID: 8814540
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Analysis of p53 and mdm-2 expression in 18 patients with Sézary syndrome.
    Marks DI; Vonderheid EC; Kurz BW; Bigler RD; Sinha K; Morgan DA; Sukman A; Nowell PC; Haines DS
    Br J Haematol; 1996 Mar; 92(4):890-9. PubMed ID: 8616082
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High incidence of potential p53 inactivation in poor outcome childhood acute lymphoblastic leukemia at diagnosis.
    Marks DI; Kurz BW; Link MP; Ng E; Shuster JJ; Lauer SJ; Brodsky I; Haines DS
    Blood; 1996 Feb; 87(3):1155-61. PubMed ID: 8562942
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expression and significance of P53 protein and MDM-2 protein in human gliomas.
    Wang AL; Liu ZX; Li G; Zhang LW
    Chin Med J (Engl); 2011 Aug; 124(16):2530-3. PubMed ID: 21933600
    [TBL] [Abstract][Full Text] [Related]  

  • 59. p53 in cutaneous melanoma: immunoreactivity and correlation with prognosis.
    Lee CS; Pirdas A; Lee MW
    Australas J Dermatol; 1995 Nov; 36(4):192-5. PubMed ID: 8593106
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mutation and expression of the p53 gene in malignant melanoma cell lines.
    Weiss J; Schwechheimer K; Cavenee WK; Herlyn M; Arden KC
    Int J Cancer; 1993 Jun; 54(4):693-9. PubMed ID: 8514460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 75.